Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 3Withdrawn 1Unknown 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Central Nervous System Neoplasms 5Glioblastoma 4Brain Neoplasms 3Astrocytoma 3Lymphoma 2Glioma 2Spinal Cord Neoplasms 1Recurrence 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma, Large-Cell, Anaplastic 1Gliosarcoma 1

Interventions

Temozolomide 5Radiotherapy 4Carmustine 3Surgical Procedures, Operative 2Hyperbaric Oxygenation 2Ethanol 2Carboplatin 2pembrolizumab 1lonafarnib 1ipatasertib 1interleukin-4-Pseudomonas exotoxin 1dactolisib 1Verteporfin 1Tamoxifen 1Procarbazine 1Phosphorus-32 1Pemetrexed 1Neoadjuvant Therapy 1Lomustine 1Erlotinib Hydrochloride 1Dihematoporphyrin Ether 1Chlorotoxin 1Chemotherapy, Adjuvant 1Brachytherapy 1Arsenic Trioxide 17-tert-butyldimethylsilyl-10-hydroxycamptothecin 12-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Gliosarcoma × Lomustine × Clear all
NCT00003788 2013-11-06

Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas

National Cancer Institute (NCI)

Phase 3 Unknown
270 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡